Abstract

The shorter cervical segment after classic radical trachelectomy (RT) imposes a number of pregnancy associated risk factors. In this aspect, large conization (LC) could be an oncologically safe alternative to RT in young women with early stage cervical cancer who want to spare their fertility. Our aim was to evaluate fertility-sparing surgical treatment of early stage cervical cancer after the introduction of LC. Our objectives were to assess surgical, oncological, fertility and obstetric outcomes. We retrospectively investigated oncological and fertility outcomes of patients who underwent LC in a large oncological single University centre between 2009 and 2014. Medical records were reviewed and analysed for surgical, oncological, fertility and obstetric outcomes. Postal questionnaires were collected to further evaluate and validate the fertility and obstetric outcomes. A total of 23 LCs were analysed. Seven patients had to undergo secondary radical hysterectomy after LC due to unclear resection margins. Nine of 16 women tried to conceive, of which all nine became pregnant. Seven patients underwent a prophylactic cerclage between 13 and 16 gestational weeks and seven women delivered 9 children; the majority of women conceived spontaneously. Follow-up time was a median of 3.9 years (2.6–8 years). There was no relapse of cervical cancer in the investigated timeframe. Early stage cervical cancers treated by LC are associated with excellent oncological outcomes. LC appears to be a safe option for eligible women who intend to maintain their fertility.

Highlights

  • Cervical cancer is the fourth most common cancer in women, and the tenth overall, with 569,847 new cases in 2018 worldwide [1]

  • In 16 women, large conization (LC) successfully led to the complete removal of cervical cancer indicated by the pathological report as clear margins (R0 resection)

  • Our study shows an acceptable level of successful LCs with strict oncologic criteria, and satisfactory oncological safety, fertility and obstetric outcomes

Read more

Summary

Introduction

Cervical cancer is the fourth most common cancer in women, and the tenth overall, with 569,847 new cases in 2018 worldwide [1]. Young women with no children are affected. In Germany, 36 out of 100,000 women between the ages of 20 and 40 are diagnosed with cervical cancer every year [2]. Due to social and economic reasons, family planning shifts towards the end of the third decade and into the fourth decade of a woman’s life. Depending on the stage of the disease, cervical cancer is traditionally treated by (radical) hysterectomy (RH) and pelvic lymph node dissection (PLND). Fertility-sparing therapy options are important to young women in their reproductive life if their oncological safety is considered

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call